Clinical Trial 39854

Chattanooga, TN 37421

Study Summary:

Moderate to Severe Atopic Dermatitis Study

A clinical trial designed to evaluate the safety and effectiveness of a new investigational medication under development for adult patients with moderate to-severe atopic dermatitis is currently being conducted.

All subjects will receive injections of trial medication every other week for up to 32 weeks. For all trial participants, the trial will include up to 20 visits to the trial clinic.

Atopic dermatitis is a chronic inflammatory skin disease. In its severe form, atopic dermatitis is characterized by widespread skin lesions, itch, as well as increased risk of skin infections. Atopic dermatitis is associated with a substantial burden that typically includes poor quality of life, sleep disturbance, and reductions in work productivity. 

Qualified Participants Must:

• Have had moderate to severe atopic dermatitis for at least 1 year to qualify

Qualified Participants May Receive:

There is no cost to participate in this clinical study and reasonable travel expenses will be reimbursed.

View Contact Phone Number

Research Site Profile

View Clinic Profile

Study is Available At:

6035 Shallowford Rd. Suite 109
Chattanooga, TN 37421
View Clinic Location


If you would like to be contacted by the clinical trial representative and live within 50 miles of this clinic, please enter your contact information, then click 'I Am Interested In This Study'

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.